New APDA Tracker App 2.0 Easier and More Detailed in English and in Spanish

New APDA Tracker App 2.0 Easier and More Detailed in English and in Spanish
0
(0)

An upgrade to the American Parkinson Disease Association (APDA) Symptom Tracker App, available to patients and caregivers at no cost, includes improvements to make for an easier and more detailed user experience and a Spanish language version.

The mobile app, first released last year, was developed to help people with Parkinson’s play a more active role in disease management.

Its new version, called the APDA Symptom Tracker App 2.0, came in response to user feedback, and patients’ expressed need to more easily and accurately track their symptoms and medications. It can be downloaded from the Apple App Store or Google Play.

Through a series of questions, users can rate how certain Parkinson’s motor and non-motor symptoms are affecting them at any given time. The tool then generates a graphic indicating which symptoms are most affecting a person’s quality of life. This chart can be saved in the app’s “My Library” section, and can also be sent directly by email to the patient’s healthcare team.

Results collected over time can help in determining whether certain symptoms are worsening, and which symptoms should be prioritized for treatment.

“As a movement disorder specialist, the more my patients tell me about their symptoms, the more I can help them. I can see how they’re feeling at that one moment, but to be able to see on a chart how they’ve been feeling at other times since I last saw them would be hugely beneficial for me,” Rebecca Gilbert, MD, PhD, the APDA’s chief scientific officer, said in a press release.

“And now if they track their medications with the app as well, it will help me see possible correlations between dosing and their symptoms,” she added. “The upgraded APDA Symptom Tracker App benefits not only the patient, but it helps me as their doctor.”

New app features include an interactive medication tracker that allows patients or caregivers to enter treatments in use, their doses, and the time of day each is taken. This helps to identify opportunities for better symptom management, since medication dosing and timing are important and can be difficult to optimally adjust in Parkinson’s.

Also new are reminders to enter symptom data and to share that information with clinicians before appointments, helping to ensure more meaningful conversations with healthcare teams.

A “Questions for the Doctor” feature offers suggested discussion topics about symptoms and concerns, as well as preventative measures. Patients can print out the questions to take to appointment.

The app can also send push notifications about educational programs and treatment updates, and features a list of resources for disease information.

Lastly, a Spanish-language app version has been created to better serve and support under-represented Parkinson’s communities.

App upgrades were sponsored by Acadia Pharmaceuticals, whose treatments for central nervous system diseases such as Parkinson’s include Nuplazid.

“With the features of this latest release … we hope to broaden the reach of this important resource for the PD community,” said Ponni Subbiah, MD, a senior vice president, global head of medical affairs and chief medical officer for Acadia.

Mary M. Chapman began her professional career at United Press International, running both print and broadcast desks. She then became a Michigan correspondent for what is now Bloomberg BNA, where she mainly covered the automotive industry plus legal, tax and regulatory issues. A member of the Automotive Press Association and one of a relatively small number of women on the car beat, Chapman has discussed the automotive industry multiple times of National Public Radio, and in 2014 was selected as an honorary judge at the prestigious Cobble Beach Concours d’Elegance. She has written for numerous national outlets including Time, People, Al-Jazeera America, Fortune, Daily Beast, MSN.com, Newsweek, The Detroit News and Detroit Free Press. The winner of the Society of Professional Journalists award for outstanding reporting, Chapman has had dozens of articles in The New York Times, including two on the coveted front page. She has completed a manuscript about centenarian car enthusiast Margaret Dunning, titled “Belle of the Concours.”
Total Posts: 208
Ana holds a PhD in Immunology from the University of Lisbon and worked as a postdoctoral researcher at Instituto de Medicina Molecular (iMM) in Lisbon, Portugal. She graduated with a BSc in Genetics from the University of Newcastle and received a Masters in Biomolecular Archaeology from the University of Manchester, England. After leaving the lab to pursue a career in Science Communication, she served as the Director of Science Communication at iMM.
×
Mary M. Chapman began her professional career at United Press International, running both print and broadcast desks. She then became a Michigan correspondent for what is now Bloomberg BNA, where she mainly covered the automotive industry plus legal, tax and regulatory issues. A member of the Automotive Press Association and one of a relatively small number of women on the car beat, Chapman has discussed the automotive industry multiple times of National Public Radio, and in 2014 was selected as an honorary judge at the prestigious Cobble Beach Concours d’Elegance. She has written for numerous national outlets including Time, People, Al-Jazeera America, Fortune, Daily Beast, MSN.com, Newsweek, The Detroit News and Detroit Free Press. The winner of the Society of Professional Journalists award for outstanding reporting, Chapman has had dozens of articles in The New York Times, including two on the coveted front page. She has completed a manuscript about centenarian car enthusiast Margaret Dunning, titled “Belle of the Concours.”
Latest Posts
  • APDA Symptom Tracker App
  • Veterans with Parkinson's
  • dementia study
  • Parkinson's Foundation and Alexa

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?